One Year of the COVID-19 Pandemic. What Do We Know and What Is Yet to Come? - The Summarising Review.
One Year of the COVID-19 Pandemic. What Do We Know and What Is Yet to Come? - The Summarising Review.
复制标题
DOI：
10.3389/ijph.2021.1603975
复制
发表时间：
2021
影响因子：
4.6
通讯作者：
Spiegel M
中科院分区：
文献类型：
--
作者：
Malchrzak W;Mastalerz-Migas A;Sroka Z;Spiegel M
目的：本文综述了近年来有关SARS- CoV-2病毒感染的最新研究成果，重点介绍了SARS- CoV-2病毒感染的病理生理机制和治疗方法。方法：于2020年11月，收集研究文章并手动检查，以挑选最相关的文章。对于新的主题，例如疫苗，我们使用足够的关键字进行搜索。对200份手稿进行了初步分析。结果：59篇文献因超范围，被剔除。另外25篇论文被拒绝，因为它们提出的主题在已经收录的论文中已经被广泛描述。基于29篇文献，我们估计了住院患者中观察到的SARS-CoV-2感染、临床表现和合并症的比例。12篇论文让我们评估了实验室标志物浓度内的偏差频率以及实验室测试结果的加权平均值。结论：由于该病毒的显著感染性及其对生物体的危害性，需要进一步研究以找到疾病治疗和阻止其传播的准确方法。
Objectives: The aim of this review is to summarize the most relevant scientific discoveries regarding SARS- CoV-2 virus infection, with the special emphasis put on its pathophysiology and way of treatment. Methods: In November 2020, the research articles have been collected and examined manually to pick the most relevant. In case of fresh topics, e.g. vaccines, we have performed searching using adequate keywords. Preliminary analysis was conducted on 200 manuscripts. Results: Among them 59 papers were out-of-scope, and thus were rejected from the further elaboration. Another 25 papers were rebuffed because they presented topics, that have been extensively described in the already included papers. Basing on the 29 papers we have estimated ratio of observed SARS-CoV-2 infection clinical manifestations and comorbidities among hospitalized patients. 12 papers let us evaluate frequencies of deviations within laboratory markers concentrations, as well as weighted average of the laboratory tests results. Conclusion: Due to the significant infectivity of the virus and its harmfulness towards organism further studies are required to find accurate way of the disease treatment and suspending its spreading.
登录
查看更多内容
DOI：
10.1056/nejmoa2022926
发表时间：
2020-11-19
期刊：
The New England journal of medicine
影响因子：
--
作者：
RECOVERY Collaborative Group;Horby P;Mafham M;Linsell L;Bell JL;Staplin N;Emberson JR;Wiselka M;Ustianowski A;Elmahi E;Prudon B;Whitehouse T;Felton T;Williams J;Faccenda J;Underwood J;Baillie JK;Chappell LC;Faust SN;Jaki T;Jeffery K;Lim WS;Montgomery A;Rowan K;Tarning J;Watson JA;White NJ;Juszczak E;Haynes R;Landray MJ
通讯作者：
Landray MJ
影响因子：
8.4
作者：
Amzat, Jimoh;Aminu, Kafayat;Danjibo, Maryann C.
通讯作者：
Danjibo, Maryann C.
DOI：
10.1056/nejmoa2035389
发表时间：
2021-02-04
期刊：
The New England journal of medicine
影响因子：
--
作者：
Baden LR;El Sahly HM;Essink B;Kotloff K;Frey S;Novak R;Diemert D;Spector SA;Rouphael N;Creech CB;McGettigan J;Khetan S;Segall N;Solis J;Brosz A;Fierro C;Schwartz H;Neuzil K;Corey L;Gilbert P;Janes H;Follmann D;Marovich M;Mascola J;Polakowski L;Ledgerwood J;Graham BS;Bennett H;Pajon R;Knightly C;Leav B;Deng W;Zhou H;Han S;Ivarsson M;Miller J;Zaks T;COVE Study Group
通讯作者：
COVE Study Group
DOI：
10.1016/j.transci.2020.102955
发表时间：
2021-03
期刊：
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
影响因子：
--
作者：
Altuntas F;Ata N;Yigenoglu TN;Bascı S;Dal MS;Korkmaz S;Namdaroglu S;Basturk A;Hacıbekiroglu T;Dogu MH;Berber İ;Dal K;Kınık K;Haznedaroglu İ;Yılmaz FM;Kılıç İ;Demircioğlu S;Yosunkaya A;Erkurt MA;Turgut B;Caglayan M;Celik O
通讯作者：
Celik O
影响因子：
82.9
作者：
He, Xi;Lau, Eric H. Y.;Leung, Gabriel M.
通讯作者：
Leung, Gabriel M.